Horizon Pharma Announces Pricing of $150M of 5.00% Convertible Senior Notes
November 19, 2013 at 07:13 AM EST
Horizon Pharma (NASDAQ: HZNP ) ("Horizon" or the "Company") today announced that it has entered into note purchase agreements with investors to issue $150 million aggregate principal amount of 5.00% Convertible Senior Notes due 2018 (the "Notes"). The initial conversion price of the Notes will be $5.36, representing a
